LAS VEGAS, March 24, 2009 (GLOBE NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT) announced results today for the first phase of the clinical trials with a FDA certified facility, Bucks County Clinical Research, Inc., and Richard M. Goldfarb, M.D., FACS. Bucks/Goldfarb has performed a Human Clinical Study on the equipment over a 10-week period. The study was on patients who suffer from being overweight, and the trials placed them through a full protocol of three 40-minute sessions per week over the test period. Documentation with statistically proven measurements has been provided to the company. The results of the study showed remarkable measurable reduction in inches and body weight over several body parts.
The patients volunteered to complete a 15-session trial utilizing 30-40 minute sessions, at least 3 times a week. These patients were not influenced to partake in the study based upon their race, sex, age and economic status. Patients were not instructed to follow a specific diet or exercise program. Once the patients agreed, they were thoroughly explained the risks and benefits of using the Cardio-Cor bike. The patients were instructed to drink 1 ounce of water per minute while riding the bike. The study documented results on each of three different measuring sessions. Measurements were taken before session 1, session 7, and after session 15. Once the information was obtained, it was statistically analyzed and organized into bar graphs.
Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated, "This pilot study demonstrated the Cardio-Cor bike aided in weight loss and inch-loss when used three times per week for 30-40 minute sessions. Volunteers lost an average total of 12.5 overall inches after using the prescribed Cardio-Cor for 30-40 minutes, 3 times per week for 5 weeks." Mr. Bailey continued, "The participants also lost an average of 4 pounds over the 5-week period."
Cardio Infrared Technologies, Inc. is committed to proving by the facts that the equipment works as represented, and the clinical trials have now provided the proof that was needed by the health and fitness industries. The continuing and ongoing clinical phase II study will show the deep cleansing afforded by the combination of exercise and infrared technology and may also demonstrate the following additional benefits:
-- Detoxifies the body of narcotic drugs and hormone disrupting
chemical residues held in the body fat and internal organs.
-- Detoxifies the body of heavy metals, hydrocarbon residues,
alcohol, nicotine, sodium and cholesterol.
-- Helps relieve pain associated with sprains, muscle spasms,
muscle soreness and joint stiffness.
-- Decreases or eliminates the amount of soreness, swelling and
lactic acid normally created through exercise.
-- Enhances circulation and oxygenates the tissues.
-- Increases the body's metabolism and relieves stress.
-- Decreases blood sugar levels.
-- Sharpens senses and relieves stress, leaving the user feeling
refreshed and rejuvenated.
-- Improves skin tone, elasticity and increases collagen.
-- Helps reduce scars, burns, and improves other unsightly or
irregular skin conditions.
-- Increases blood circulation and stimulates deep cleansing of
impurities in the bloodstream.
-- Improves the immune system by increasing the immune power of
the leukocyte, macrophage, NK cells and activates T cells
(the immune power is strengthened over 200 times by raising
the body core temperature up to 3.5 degrees C).
About Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies, Inc. is a technology and marketing company which is focused on developing the revolutionary and evolutionary process of combining exercise equipment with medical benefits that go far beyond the normal benefits of standard exercise equipment. Cardio Infrared Technologies, Inc. is committed to continue to market this equipment to the exercise and medical markets and to aggressively expand the market to every country around the world. The equipment has already been featured on Good Morning America and The View. Cardio Infrared Technologies, Inc. also has an aggressive growth plan that includes acquisitions and development of innovate new equipment in the exercise and medical industries.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.The words or phrases "would be," "would allow," "intends to'" "will likely result," "are expected to," "will continue," "anticipate," "expect," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "considers," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. These include the company's historic lack of profitability, end user customer acceptance and actual demand, which may differ significantly from expectations, the need for the company to manage its growth, the need to raise funds for operations and other risks within the regulation of the industry. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, events or circumstances after the date of such statement.